ID   SIAS_HUMAN              Reviewed;         359 AA.
AC   Q9NR45; B2RE98; Q8WUV9; Q9BWS6; Q9NVD4;
DT   15-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2002, sequence version 2.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=Sialic acid synthase;
DE   AltName: Full=N-acetylneuraminate synthase;
DE            EC=2.5.1.56;
DE   AltName: Full=N-acetylneuraminate-9-phosphate synthase;
DE            EC=2.5.1.57;
DE   AltName: Full=N-acetylneuraminic acid phosphate synthase;
DE   AltName: Full=N-acetylneuraminic acid synthase;
GN   Name=NANS; Synonyms=SAS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   TISSUE=Liver;
RX   PubMed=10749855; DOI=10.1074/jbc.M000217200;
RA   Lawrence S.M., Huddleston K.A., Pitts L.R., Nguyen N., Lee Y.C.,
RA   Vann W.F., Coleman T.A., Betenbaugh M.J.;
RT   "Cloning and expression of the human N-acetylneuraminic acid phosphate
RT   synthase gene with 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid
RT   biosynthetic ability.";
RL   J. Biol. Chem. 275:17869-17877(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASP-68.
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-11; 132-145; 150-166; 247-264 AND 299-315,
RP   CLEAVAGE OF INITIATOR METHIONINE, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-79, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   INVOLVEMENT IN SEMDG, AND VARIANTS SEMDG ASN-29; VAL-133; HIS-151;
RP   HIS-188; LEU-189; CYS-237 AND ILE-327 INS.
RX   PubMed=27213289; DOI=10.1038/ng.3578;
RA   van Karnebeek C.D., Bonafe L., Wen X.Y., Tarailo-Graovac M.,
RA   Balzano S., Royer-Bertrand B., Ashikov A., Garavelli L., Mammi I.,
RA   Turolla L., Breen C., Donnai D., Cormier V., Heron D., Nishimura G.,
RA   Uchikawa S., Campos-Xavier B., Rossi A., Hennet T.,
RA   Brand-Arzamendi K., Rozmus J., Harshman K., Stevenson B.J.,
RA   Girardi E., Superti-Furga G., Dewan T., Collingridge A., Halparin J.,
RA   Ross C.J., Van Allen M.I., Rossi A., Engelke U.F., Kluijtmans L.A.,
RA   van der Heeft E., Renkema H., de Brouwer A., Huijben K., Zijlstra F.,
RA   Heisse T., Boltje T., Wasserman W.W., Rivolta C., Unger S.,
RA   Lefeber D.J., Wevers R.A., Superti-Furga A.;
RT   "NANS-mediated synthesis of sialic acid is required for brain and
RT   skeletal development.";
RL   Nat. Genet. 48:777-784(2016).
RN   [12]
RP   STRUCTURE BY NMR OF 294-359.
RX   PubMed=16597820; DOI=10.1110/ps.051700406;
RA   Hamada T., Ito Y., Abe T., Hayashi F., Guentert P., Inoue M.,
RA   Kigawa T., Terada T., Shirouzu M., Yoshida M., Tanaka A., Sugano S.,
RA   Yokoyama S., Hirota H.;
RT   "Solution structure of the antifreeze-like domain of human sialic acid
RT   synthase.";
RL   Protein Sci. 15:1010-1016(2006).
CC   -!- FUNCTION: Produces N-acetylneuraminic acid (Neu5Ac) and 2-keto-3-
CC       deoxy-D-glycero-D-galacto-nononic acid (KDN). Can also use N-
CC       acetylmannosamine 6-phosphate and mannose 6-phosphate as
CC       substrates to generate phosphorylated forms of Neu5Ac and KDN,
CC       respectively.
CC   -!- CATALYTIC ACTIVITY: Phosphoenolpyruvate + N-acetyl-D-mannosamine +
CC       H(2)O = phosphate + N-acetylneuraminate.
CC   -!- CATALYTIC ACTIVITY: Phosphoenolpyruvate + N-acyl-D-mannosamine 6-
CC       phosphate + H(2)O = N-acylneuraminate 9-phosphate + phosphate.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Spondyloepimetaphyseal dysplasia, Genevieve type (SEMDG)
CC       [MIM:610442]: An autosomal recessive disorder characterized by
CC       global developmental delay with infantile onset, mental
CC       retardation, skeletal dysplasia, and short stature. Skeletal
CC       findings include flat vertebral bodies with irregular vertebral
CC       plates, irregular and flared metaphyses with vertical striations,
CC       small and irregular epiphyses, premature carpal ossification and
CC       small carpal bones. {ECO:0000269|PubMed:27213289}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF257466; AAF75261.1; -; mRNA.
DR   EMBL; AK001659; BAA91818.1; -; mRNA.
DR   EMBL; AK316608; BAG38195.1; -; mRNA.
DR   EMBL; AL137073; CAI13886.1; -; Genomic_DNA.
DR   EMBL; CH471105; EAW58867.1; -; Genomic_DNA.
DR   EMBL; BC000008; AAH00008.1; -; mRNA.
DR   EMBL; BC019315; AAH19315.1; -; mRNA.
DR   CCDS; CCDS6733.1; -.
DR   RefSeq; NP_061819.2; NM_018946.3.
DR   UniGene; Hs.522310; -.
DR   UniGene; Hs.665191; -.
DR   PDB; 1WVO; NMR; -; A=294-359.
DR   PDBsum; 1WVO; -.
DR   ProteinModelPortal; Q9NR45; -.
DR   SMR; Q9NR45; -.
DR   BioGrid; 119921; 37.
DR   IntAct; Q9NR45; 19.
DR   MINT; MINT-5002014; -.
DR   STRING; 9606.ENSP00000210444; -.
DR   iPTMnet; Q9NR45; -.
DR   PhosphoSitePlus; Q9NR45; -.
DR   SwissPalm; Q9NR45; -.
DR   BioMuta; NANS; -.
DR   DMDM; 20978759; -.
DR   REPRODUCTION-2DPAGE; IPI00147874; -.
DR   EPD; Q9NR45; -.
DR   MaxQB; Q9NR45; -.
DR   PaxDb; Q9NR45; -.
DR   PeptideAtlas; Q9NR45; -.
DR   PRIDE; Q9NR45; -.
DR   DNASU; 54187; -.
DR   Ensembl; ENST00000210444; ENSP00000210444; ENSG00000095380.
DR   GeneID; 54187; -.
DR   KEGG; hsa:54187; -.
DR   UCSC; uc004ayc.4; human.
DR   CTD; 54187; -.
DR   DisGeNET; 54187; -.
DR   GeneCards; NANS; -.
DR   HGNC; HGNC:19237; NANS.
DR   HPA; HPA019223; -.
DR   MalaCards; NANS; -.
DR   MIM; 605202; gene.
DR   MIM; 610442; phenotype.
DR   neXtProt; NX_Q9NR45; -.
DR   OpenTargets; ENSG00000095380; -.
DR   PharmGKB; PA134978885; -.
DR   eggNOG; ENOG410IHMI; Eukaryota.
DR   eggNOG; COG2089; LUCA.
DR   GeneTree; ENSGT00390000011081; -.
DR   HOGENOM; HOG000284783; -.
DR   HOVERGEN; HBG000665; -.
DR   InParanoid; Q9NR45; -.
DR   KO; K05304; -.
DR   OMA; AYPSKIE; -.
DR   OrthoDB; EOG091G0D9G; -.
DR   PhylomeDB; Q9NR45; -.
DR   TreeFam; TF324826; -.
DR   BioCyc; MetaCyc:HS01818-MONOMER; -.
DR   BRENDA; 2.5.1.57; 2681.
DR   Reactome; R-HSA-4085001; Sialic acid metabolism.
DR   ChiTaRS; NANS; human.
DR   EvolutionaryTrace; Q9NR45; -.
DR   GeneWiki; NANS; -.
DR   GenomeRNAi; 54187; -.
DR   PRO; PR:Q9NR45; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000095380; -.
DR   CleanEx; HS_NANS; -.
DR   ExpressionAtlas; Q9NR45; baseline and differential.
DR   Genevisible; Q9NR45; HS.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0050462; F:N-acetylneuraminate synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008781; F:N-acylneuraminate cytidylyltransferase activity; NAS:UniProtKB.
DR   GO; GO:0047444; F:N-acylneuraminate-9-phosphate synthase activity; TAS:Reactome.
DR   GO; GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro.
DR   GO; GO:0006055; P:CMP-N-acetylneuraminate biosynthetic process; NAS:UniProtKB.
DR   Gene3D; 3.20.20.70; -; 1.
DR   InterPro; IPR006190; AFP_Neu5c_C.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR006013; Antifreeze_III.
DR   InterPro; IPR013132; Neu5Ac_N.
DR   InterPro; IPR013974; SAF.
DR   Pfam; PF03102; NeuB; 1.
DR   PRINTS; PR00357; ANTIFREEZIII.
DR   SMART; SM00858; SAF; 1.
DR   SUPFAM; SSF51269; SSF51269; 1.
DR   PROSITE; PS50844; AFP_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Dwarfism;
KW   Mental retardation; Polymorphism; Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.6}.
FT   CHAIN         2    359       Sialic acid synthase.
FT                                /FTId=PRO_0000097750.
FT   DOMAIN      294    353       AFP-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00021}.
FT   MOD_RES      79     79       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT      29     29       H -> N (in SEMDG).
FT                                {ECO:0000269|PubMed:27213289}.
FT                                /FTId=VAR_076571.
FT   VARIANT      68     68       E -> D (in dbSNP:rs1058446).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_013308.
FT   VARIANT     133    133       G -> V (in SEMDG).
FT                                {ECO:0000269|PubMed:27213289}.
FT                                /FTId=VAR_076572.
FT   VARIANT     151    151       R -> H (in SEMDG; dbSNP:rs140402727).
FT                                {ECO:0000269|PubMed:27213289}.
FT                                /FTId=VAR_076573.
FT   VARIANT     188    188       Y -> H (in SEMDG).
FT                                {ECO:0000269|PubMed:27213289}.
FT                                /FTId=VAR_076574.
FT   VARIANT     189    189       P -> L (in SEMDG).
FT                                {ECO:0000269|PubMed:27213289}.
FT                                /FTId=VAR_076575.
FT   VARIANT     237    237       R -> C (in SEMDG).
FT                                {ECO:0000269|PubMed:27213289}.
FT                                /FTId=VAR_076576.
FT   VARIANT     327    327       I -> II (in SEMDG).
FT                                {ECO:0000269|PubMed:27213289}.
FT                                /FTId=VAR_076577.
FT   CONFLICT    232    232       A -> T (in Ref. 2; BAA91818).
FT                                {ECO:0000305}.
FT   CONFLICT    321    321       G -> A (in Ref. 1; AAF75261).
FT                                {ECO:0000305}.
FT   STRAND      294    299       {ECO:0000244|PDB:1WVO}.
FT   HELIX       309    311       {ECO:0000244|PDB:1WVO}.
FT   STRAND      312    315       {ECO:0000244|PDB:1WVO}.
FT   STRAND      324    326       {ECO:0000244|PDB:1WVO}.
FT   HELIX       327    330       {ECO:0000244|PDB:1WVO}.
FT   STRAND      334    337       {ECO:0000244|PDB:1WVO}.
FT   HELIX       347    349       {ECO:0000244|PDB:1WVO}.
FT   STRAND      356    358       {ECO:0000244|PDB:1WVO}.
SQ   SEQUENCE   359 AA;  40308 MW;  2E02D47F4F98592F CRC64;
     MPLELELCPG RWVGGQHPCF IIAEIGQNHQ GDLDVAKRMI RMAKECGADC AKFQKSELEF
     KFNRKALERP YTSKHSWGKT YGEHKRHLEF SHDQYRELQR YAEEVGIFFT ASGMDEMAVE
     FLHELNVPFF KVGSGDTNNF PYLEKTAKKG RPMVISSGMQ SMDTMKQVYQ IVKPLNPNFC
     FLQCTSAYPL QPEDVNLRVI SEYQKLFPDI PIGYSGHETG IAISVAAVAL GAKVLERHIT
     LDKTWKGSDH SASLEPGELA ELVRSVRLVE RALGSPTKQL LPCEMACNEK LGKSVVAKVK
     IPEGTILTMD MLTVKVGEPK GYPPEDIFNL VGKKVLVTVE EDDTIMEELV DNHGKKIKS
//
